We are live on !
Find out more
Brandywine Managers Portfolio holdings
AUM
$202M
Turnover
13.04%
1-Year Est. Return
16.99%
This Fund
S&P 500
This Quarter Est. Return
-1.62%
1 Year Est. Return
+16.99%
3 Year Est. Return
+96.29%
5 Year Est. Return
+26.97%
10 Year Est. Return
+345.77%
AUM
$59.3M
AUM Growth
-$92.2M
(-61%)
Cap. Flow
-$90.6M
Cap. Flow % of AUM
Cap. Flow %
-152.84%
Top 10 Holdings %
Top 10 Hldgs %
76.36%
Holding
49
New
1
Increased
2
Reduced
1
Closed
11
Avg Time Held
3.4
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$1.65M |
| 2 |
UiPath
PATH
|
+$694K |
| 3 |
Structure Therapeutics
GPCR
|
+$354K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$23.9M |
| 2 |
Philip Morris
PM
|
+$20.2M |
| 3 |
Automatic Data Processing
ADP
|
+$11.7M |
| 4 |
Starbucks
SBUX
|
+$10.7M |
| 5 |
Keurig Dr Pepper
KDP
|
+$9.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.81% |
| 2 | Miscellaneous | 35.35% |
| 3 | Healthcare | 13.72% |
| 4 | Consumer Staples | 1.66% |
| 5 | Financials | 1.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares MSCI ACWI ETF
ACWI
$32.8B
| $20.9M | 35.35% |
226,783
+17,165
| +8% | +$1.65M |
2023 Q1
2 quarters
|
|
|
2
UiPath
PATH
$7.33B
| $11.2M | 18.87% |
653,456
+41,692
| +7% | +$694K |
2021 Q2
9 quarters
|
|
3
CrowdStrike
CRWD
$274B
| $4.8M | 8.1% |
114,720
| – | – |
2019 Q2
17 quarters
|
|
4
NVIDIA
NVDA
$5.26T
| $1.55M | 2.62% |
35,640
| – | – |
2020 Q1
14 quarters
|
|
5
Salesforce
CRM
$198B
| $1.4M | 2.37% |
6,913
| – | – |
2020 Q3
12 quarters
|
|
6
Uber
UBER
$134B
| $1.23M | 2.08% |
26,740
| – | – |
2023 Q1
2 quarters
|
|
7
Zscaler
ZS
$42.4B
| $1.15M | 1.94% |
7,407
| – | – |
2018 Q4
19 quarters
|
|
8
Intuitive Surgical
ISRG
$158B
| $1.02M | 1.72% |
3,495
| – | – |
2017 Q3
24 quarters
|
|
9
Campbell Soup
CPB
$6.17B
| $986K | 1.66% |
24,014
| – | – |
2014 Q3
36 quarters
|
|
10
Moderna
MRNA
$83B
| $982K | 1.66% |
9,510
| – | – |
2018 Q4
19 quarters
|
|
11
Palo Alto Networks
PANW
$329B
| $869K | 1.47% |
7,410
| – | – |
2020 Q2
13 quarters
|
|
12
Okta
OKTA
$39.5B
| $835K | 1.41% |
10,248
| – | – |
2017 Q3
24 quarters
|
|
13
Natera
NTRA
$59.2B
| $820K | 1.38% |
18,534
-3,000
| -14% | -$153K |
2017 Q3
24 quarters
|
|
14
Alnylam Pharmaceuticals
ALNY
$30.3B
| $816K | 1.38% |
4,608
| – | – |
2018 Q4
19 quarters
|
|
15
Veeva Systems
VEEV
$50.8B
| $797K | 1.35% |
3,919
| – | – |
2017 Q2
25 quarters
|
|
16
Advanced Micro Devices
AMD
$915B
| $750K | 1.27% |
7,299
| – | – |
2022 Q1
6 quarters
|
|
17
Mastercard
MA
$534B
| $707K | 1.19% |
1,785
| – | – |
2022 Q2
5 quarters
|
|
18
PagerDuty
PD
$1.4B
| $686K | 1.16% |
30,517
| – | – |
2019 Q2
17 quarters
|
|
19
Datadog
DDOG
$101B
| $656K | 1.11% |
7,200
| – | – |
2019 Q3
16 quarters
|
|
20
Samsara
IOT
$25.5B
| $594K | 1% |
23,578
| – | – |
2021 Q4
7 quarters
|
|
21
Schrodinger
SDGR
$2B
| $590K | 1% |
20,886
| – | – |
2020 Q1
14 quarters
|
|
22
Twilio
TWLO
$39.1B
| $573K | 0.97% |
9,782
| – | – |
2018 Q1
22 quarters
|
|
|
23
Structure Therapeutics
GPCR
$1.54B
| $555K | 0.94% |
+11,000
| New | +$354K |
2023 Q3
0 quarters
|
|
24
Mobileye
MBLY
$5.84B
| $543K | 0.92% |
13,067
| – | – |
2022 Q4
3 quarters
|
|
25
ServiceNow
NOW
$160B
| $499K | 0.84% |
4,465
| – | – |
2016 Q4
27 quarters
|
|
Similar funds
OPL
LAMC
Brandywine Managers's Q3 2023 Portfolio in Review
As of Q3 2023, Brandywine Managers held 49 positions worth $59.3M, down 61% from $151M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Brandywine Managers withdrew a net $90.6M in Q3 2023, closing 11 positions and reducing 1 holding. Its most notable exit was Procter & Gamble, an estimated $23.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 30% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, Brandywine Managers opened a new position in Structure Therapeutics worth $555K.
- Brandywine Managers's largest Q3 2023 buy was Structure Therapeutics: 11,000 shares worth $555K.
- Brandywine Managers added most to iShares MSCI ACWI ETF in Q3 2023, an estimated $1.65M increase.
- Brandywine Managers's biggest Q3 2023 reduction was Natera, cutting an estimated $153K.
- Brandywine Managers fully exited Procter & Gamble in Q3 2023, selling an estimated $23.9M.
- Brandywine Managers's ten largest holdings make up 76% of its $59.3M portfolio in Q3 2023.
- Brandywine Managers opened 1 new position and closed 11 in Q3 2023.
- Brandywine Managers's portfolio value fell 61% quarter-over-quarter to $59.3M.
Based on Brandywine Managers's 13F filing for Q3 2023, filed 14 Nov 2023.